GlassScriptPhysician profile
Hamad Mohamed
NPI 1225710387
$622.07
in general payments reported to CMS, 2019-2025
11 companies · $622 in 2025
The $622 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $146.88 | 2025 | |
| Emd Serono, INC. | $124.50 | 2025 | Mavenclad |
| Argenx US, INC. | $91.40 | 2025 | Vyvgart, Vyvgart Hytrulo |
| Neurocrine Biosciences, INC. | $69.56 | 2025 | |
| Mallinckrodt Hospital Products INC. | $53.85 | 2025 | Acthar |
| Genzyme Corporation | $42.34 | 2025 | |
| Ucb, INC. | $26.31 | 2025 | Rystiggo |
| Astrazeneca Pharmaceuticals LP | $20.45 | 2025 | |
| Novartis Pharmaceuticals Corporation | $17.17 | 2025 | |
| Jazz Pharmaceuticals INC. | $15.07 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $14.54 | 2025 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamad Mohamed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.